Liu, Hung-Yu
Lee, Pei-Lin
Chou, Kun-Hsien
Lai, Kuan-Lin
Wang, Yen-Feng
Chen, Shih-Pin
Chen, Wei-Ta
Wang, Shuu-Jiun
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (107-2314-B-075-058-MY3, 106-2221-E-010-011-MY3, 107-2221-E-010-010-MY3, 107-2314-B-075 -015 -MY2, 108-2321-B-010-014-MY2, 108-2321-B-010-001-MY3, 108-2314-B-010-023-MY3)
Taipei Veterans General Hospital (V108C-129)
Article History
Received: 25 January 2020
Accepted: 9 March 2020
First Online: 18 March 2020
Ethics approval and consent to participate
: All participants completed informed consent forms after receiving a complete explanation of the study. The Institutional Review Board of Taipei Veterans General Hospital approved the study protocol.
: Not applicable.
: HY Liu, PL Lee, KH Chou, KL Lai, YF Wang, SP Chen, and WT Chen have no conflict of interest to declare.SJ Wang has served on the advisory boards of Eli Lilly, Daiichi-Sankyo, Taiwan Pfizer and Taiwan Norvatis. He has received honoraria as a moderator from Allergan, Pfizer, Eli Lilly, Bayer, and Eisai.